Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease sarcoidosis
Comorbidity C0034069|pulmonary fibrosis
Sentences 5
PubMedID- 22075486 The objectives of this study were to compare the survival of sarcoid patients with pulmonary fibrosis with that of the general population and to determine the causes of death and the incidence of evolutive complications.
PubMedID- 22978780 Deciding which sarcoidosis patients with signs of pulmonary fibrosis may benefit from pharmacological treatment remains a challenge to clinicians, as it is not always clear whether respiratory symptoms in these patients are a result of organ damage or due to ongoing inflammation or both.
PubMedID- 21330454 Among young sarcoidosis decedents, those with pulmonary fibrosis or a cardiac cause contributing to death were more likely to be black than white.
PubMedID- 21214523 This study is the first to suggest that genetic variation of grem1 predisposes to pulmonary fibrosis in sarcoidosis patients.
PubMedID- 23720838 The sarcoidosis patients with signs of pulmonary fibrosis and no symptoms of disease inflammatory activity had elevated blood il-1 levels whereas an il-1 receptor antagonist was decreased.

Page: 1